You have 9 free searches left this month | for more free features.

romidepsin

Showing 26 - 50 of 58

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hematologic Malignancy, Malignant Lymphoma Trial in Sarasota, Nashville, London (Romidepsin, Ketoconazole)

Completed
  • Hematologic Malignancy
  • Malignant Lymphoma
  • Sarasota, Florida
  • +2 more
Nov 14, 2019

Pancreatic Cancer Trial in Nashville (Romidepsin, Gemcitabine)

Completed
  • Pancreatic Cancer
  • Nashville, Tennessee
    Sarah Cannon Research Institute
Oct 16, 2019

Multiple Myeloma Trial in United States (Bortezomib, Romidepsin)

Terminated
  • Multiple Myeloma
  • Loma Linda, California
  • +11 more
Nov 14, 2019

Prostate Cancer, Metastases Trial (Romidepsin)

Completed
  • Prostate Cancer
  • Metastases
  • Romidepsin
  • (no location specified)
Nov 14, 2019

Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Stage I Cutaneous T-cell

Terminated
  • Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma
  • +13 more
  • Chicago, Illinois
    Northwestern University
Jul 24, 2019

Lymphoma, T-Cell, Peripheral Trial (Romidepsin, Pralatrexate)

Withdrawn
  • Lymphoma, T-Cell, Peripheral
  • (no location specified)
Dec 17, 2018

Peripheral T-cell Lymphoma Trial in Worldwide (Romidepsin)

Completed
  • Peripheral T-cell Lymphoma
  • Romidepsin
  • La Jolla, California
  • +89 more
Jan 29, 2020

Lymphoma, T-cell, Peripheral Trial in Japan (Romidepsin)

Completed
  • Lymphoma, T-cell, Peripheral
  • Romidepsin
  • Nagoya, Aichi, Japan
  • +16 more
Jan 28, 2019

Multiple Myeloma Trial in New York (Romidepsin, pomalidomide, Dexamethasone)

Terminated
  • Multiple Myeloma
  • Romidepsin
  • +2 more
  • New York, New York
    Weill Cornell Medical College
May 31, 2018

Leukemia, Lymphoma Trial in United States (Bortezomib, Romidepsin)

Completed
  • Leukemia
  • Lymphoma
  • Chicago, Illinois
  • +4 more
Apr 19, 2018

HER2-negative Breast Cancer, Inflammatory Breast Cancer, Male Breast Cancer Trial in Philadelphia (Romidepsin, Abraxane)

Terminated
  • HER2-negative Breast Cancer
  • +4 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Dec 4, 2017

HIV Trial in Badalona, Barcelona (MVA.HIVconsv vaccine, Romidepsin)

Completed
  • HIV
  • MVA.HIVconsv vaccine
  • Romidepsin
  • Badalona, Barcelona, Spain
  • +1 more
Jan 16, 2018

Relapsed Peripheral T-Cell Lymphoma, Refractory Peripheral T-Cell Lymphoma Trial in Worldwide (Alisertib, Pralatrexate,

Completed
  • Relapsed Peripheral T-Cell Lymphoma
  • Refractory Peripheral T-Cell Lymphoma
  • Birmingham, Alabama
  • +151 more
Jul 6, 2018

GVHD Trial in New Brunswick (romidepsin, laboratory biomarker analysis)

Terminated
  • Graft Versus Host Disease
  • romidepsin
  • laboratory biomarker analysis
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Feb 13, 2017

Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma Trial (romidepsin)

Completed
  • Adult Alveolar Soft-part Sarcoma
  • +19 more
  • romidepsin
  • (no location specified)
May 18, 2017

HIV I Infection Trial in Aarhus N (Romidepsin, Vacc-4x, rhuGM-CSF)

Completed
  • HIV I Infection
  • Romidepsin
  • +2 more
  • Aarhus N, Denmark
    Aarhus University Hospital, Skejby Sygehus
Jan 11, 2017

PTCL, CTCL Trial (Volasertib, Romidepsin)

Withdrawn
  • PTCL
  • CTCL
  • (no location specified)
Nov 29, 2016

Cutaneous T Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Australia, United States (Romidepsin)

Completed
  • Cutaneous T Cell Lymphoma
  • Peripheral T Cell Lymphoma
  • Romidepsin
  • Scottsdale, Arizona
  • +12 more
Apr 13, 2017

Long-term Use of Romidepsin in Patients With CTCL

Completed
  • Cutaneous T-cell Lymphoma
  • Romidepsin
  • Chicago, Illinois
    Northwestern University Dermatology Department
Mar 10, 2016

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Completed
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +7 more
  • romidepsin
  • Chicago, Illinois
  • +1 more
Dec 3, 2015

Lymphoma Trial run by the NCI (romidepsin)

Completed
  • Lymphoma
  • romidepsin
  • Bethesda, Maryland
    Medicine Branch
Apr 28, 2015

DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Bronx (Romidepsin,

Completed
  • DS Stage II Plasma Cell Myeloma
  • +2 more
  • Romidepsin
  • Laboratory Biomarker Analysis
  • Bronx, New York
    Montefiore Medical Center - Moses Campus
Mar 16, 2015

Recurrent Thyroid Cancer, Stage IV Follicular Thyroid Cancer, Stage IV Papillary Thyroid Cancer Trial in Commack (drug, other,

Completed
  • Recurrent Thyroid Cancer
  • +2 more
  • romidepsin
  • +2 more
  • Commack, New York
    Memorial Sloan-Kettering Cancer Center at Suffolk
May 13, 2014

Recurrent Small Cell Lung Cancer Trial in Columbus (romidepsin, laboratory biomarker analysis)

Completed
  • Recurrent Small Cell Lung Cancer
  • romidepsin
  • laboratory biomarker analysis
  • Columbus, Ohio
    Ohio State University
Apr 9, 2014

Histologically Proven Extranodal NKTcell Lymphoma Trial in Korea, Republic of (Romidepsin)

Completed
  • Histologically Proven Extranodal NKTcell Lymphoma
  • Romidepsin
  • Goyang-si, Gyeonggi-do, Korea, Republic of
  • +3 more
Jul 29, 2013